logo

TKNO

Alpha Teknova·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 1
Revenue Beats Expectation
EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About TKNO

Alpha Teknova, Inc.

A leading provider of critical reagents for bioprocessing, bioproduction diagnostics for research, clinical, and applied markets

Pharmaceutical
05/30/2000
06/25/2021
NASDAQ Stock Exchange
173
12-31
Common stock
2451 Bert Dr., Hollister, CA 95023
--
Alpha Teknova, Inc., was originally incorporated in California on May 30, 2000 as "eTeknova Inc. ". On January 11, 2019, the Company filed a certificate of merger and merged with Alpha Teknova, Inc., a Delaware corporation, which continues as a surviving entity under the corporate name "Alpha Teknova, Inc.". The company is a leading supplier of key reagents, capable of discovering, developing and producing biopharmaceutical products such as drug therapies, new vaccines, molecular diagnostics, etc. The company's 3,000 active customers span the continuum of the life sciences market, including leading pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company is built around a highly adaptable and versatile proprietary development and manufacturing process. These proprietary processes enable the manufacture and delivery of high-quality, customized, made-to-order products with short turnaround time and scale at all stages of customer product development (including commercialization).

Earnings Call

Company Financials

EPS

TKNO has released its 2025 Q3 earnings. EPS was reported at -0.08, versus the expected -0.09, beating expectations. The chart below visualizes how TKNO has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

TKNO has released its 2025 Q3 earnings report, with revenue of 10.45M, reflecting a YoY change of 9.17%, and net profit of -4.29M, showing a YoY change of 43.34%. The Sankey diagram below clearly presents TKNO's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime